Hydroxyapatite is a primary inorganic component of human hard tissues such as bones and teeth. It has excellent biocompatibility and osteoconductivity properties. Hydroxyapatite coatings are used in orthopedic and dental implants to form a strong bond with bones, enhance new bone formation, and speed up recovery. These coatings offer superior strength and help replicate the natural composition of bones, resulting in better integration of implants. Moreover, hydroxyapatite granules/pastes are often used as bone void fillers and replacements in orthopedic procedures for fractures.
The global Hydroxyapatite Market is estimated to be valued at US$ 2 billion in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The demand for hydroxyapatite has been rising sharply from the orthopedic and dental industries over the past few years. The increasing volume of orthopedic and dental surgical procedures owing to the growing geriatric population and road accidents has fueled the consumption of hydroxyapatite products. Hydroxyapatite coatings provide enhanced osteoconductivity and help implants bond better with bones, reducing the need for revision surgeries. This has further augmented the uptake of hydroxyapatite in medical applications.
Segment Analysis
The global hydroxyapatite market is dominated by medical grade hydroxyapatite segment. Medical grade hydroxyapatite finds wide range applications in orthopedic, dental and plastic surgeries owing to its biocompatibility and osteoconductivity properties. It is widely used as bone graft substitutes and coatings for orthopedic and dental implants. Growing demand for biocompatible and biodegradable synthetic bone grafts and rising number of bone fractures, accidents and ageing population are some of the factors driving the demand for medical grade hydroxyapatite.
Key Takeaways
The Global Hydroxyapatite Market Demand is expected to witness high growth led by rising demand for dental and orthopaedic applications. The global Hydroxyapatite Market is estimated to be valued at US$ 2 billion in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030.
Regional analysis: North America accounts for the largest share in the global hydroxyapatite market followed by Europe and Asia Pacific. The growth in North America can be attributed to growing healthcare spending, rising number of surgeries and increasing R&D investments in the region. Asia Pacific is expected to witness fastest growth owing to rising healthcare expenditure, growing medical tourism industry and increasing prevalence of osteoporosis in countries like China and India.
Key players: The key players operating in the hydroxyapatite market are SofSera, Fluidinova, Bio-Rad, Bonesupport AB, GE Healthcare, Sigma Graft, Berkeley Advanced Biomaterials, Zimmer Biomet, Nano Interface Technology, and Cam Bioceramics. Bonesupport AB offers Apaptite, an injectable bone graft substitute composed of 100% synthetic nano-crystalline hydroxyapatite. Zimmer Biomet provides TruFit CB Bone Cement, a bioactive bone cement composed of hydroxyapatite and calcium phosphate for orthopedic bone repairs.
Explore more information on this topic, Please visit-
Explore more trending article related this topic:
